07:12:49 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-14 Kvartalsrapport 2024-Q3
2024-08-22 Kvartalsrapport 2024-Q2
2024-05-29 Ordinarie utdelning CIRCA 0.00 NOK
2024-05-28 Årsstämma 2024
2024-05-15 Kvartalsrapport 2024-Q1
2024-02-15 Bokslutskommuniké 2023
2023-11-09 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-26 Ordinarie utdelning CIRCA 0.00 NOK
2023-05-25 Årsstämma 2023
2023-05-11 Kvartalsrapport 2023-Q1
2023-02-16 Bokslutskommuniké 2022
2022-11-17 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-03 Ordinarie utdelning CIRCA 0.00 NOK
2022-06-02 Årsstämma 2022
2022-05-24 Kvartalsrapport 2022-Q1
2022-03-02 Bokslutskommuniké 2021
2021-11-25 Kvartalsrapport 2021-Q3
2021-08-26 Kvartalsrapport 2021-Q2
2021-06-17 Ordinarie utdelning CIRCA 0.00 NOK
2021-06-16 Årsstämma 2021
2021-05-27 Kvartalsrapport 2021-Q1
2021-03-02 Bokslutskommuniké 2020

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriBioteknik
Circa Group är verksamma inom bioteknik. Bolaget är en utvecklare av biokemikalier som vidare används för omvandling av avfallsmassa till diverse biokemiskt material. Tekniken används inom energisektorn vid olika produktionsprocesser. Bolaget grundades under 2006 och innehar störst verksamhet runtom den europeiska marknaden. Circa Group har sitt huvudkontor i Oslo, Norge.
2023-11-01 07:00:00
OSLO, NORWAY - 1 NOVEMBER 2023 - Circa Group AS (stock symbol: CIRCA) today
announced that Dr Steve Döring, the designated candidate for the position of
Chief Executive Officer, has made the difficult decision not to assume the role
due to personal reasons.

Steve Döring, who was announced as the incoming CEO in May 2023, has expressed
his heartfelt gratitude for the opportunity to join Circa. However, personal
circumstances have arisen that will prevent him from taking on the role of CEO
at this time.

Circa's Board of Directors respects Steve Döring's decision and are grateful to
count on Tony Duncan, the current Chief Executive Officer, to continue to lead
the company as it focuses on the realization of the ReSolute project.

Tony has expressed his unwavering commitment to the organization and its
stakeholders and is dedicated to ensuring the continuity of Circa's vision of
"Changing Chemistry for Good".

Circa's Board of Directors will commence a search for a new CEO to lead the
company into the future. The Board remains confident in the strength of the
organization and its ability to navigate this transition with resilience and
determination.

Martin Laudenbach, Chair of the Board of Directors, stated, "While we are
disappointed that Steve Döring will not be joining us at this time, we
understand the importance of personal matters and we are committed to finding
the right leader to succeed the co-founder and long-time CEO Tony Duncan to
ensure Circa's continued success."


About Circa
Established in 2006, Circa Group converts sustainable, non-food biomass into
advanced bio-based chemicals with its proprietary FuracellTM process. Its
developing product portfolio includes flavours, biopolymers, and bio-solvents
including CyreneTM. By creating renewable chemicals from cellulose, Circa is
extracting value from non-food biomass and addressing a gap in the market by
providing bio-based, less carbon intensive alternatives, contributing to a more
circular economy.
https://circa-group.com


Investor Contact
Tone Leivestad
Chief Financial Officer
Circa Group AS
tone.leivestad@circa-group.com
Tel: +47 406 39 455

Media Contact
Kathryn Sheridan
Sustainability Consult
ks@sustainabilityconsult.com